European Association for the Study of the Liver

April 7, 2016April 7, 2016

Eiger BioPharma to Present Its Hepatitis Delta Virus Development Program at EASL Meeting

News

Eiger BioPharmaceuticals announced that studies from its Hepatitis Delta Virus (HDV) development program will be presented at the upcoming European Association for the Study of the Liver (EASL) conference April 13-17 in Barcelona, Spain. Also, interim ... Read more

April 13, 2015April 13, 2015

Clinical Data on Janssen’s Simeprevir for HCV to Feature at International Liver Congress

Hepatitis C, News

Janssen Sciences Ireland UC is going to present clinical data regarding its NS3/4A protease inhibitor, called simeprevir, to treat hepatitis C virus (HCV) infections at the upcoming International Liver Congress 2015. The ... Read more

March 2, 2015March 2, 2015

Ciclofilin Pharmaceuticals to Present Abstract on Hepatitis Antiviral at EASL 2015

News

Ciclofilin Pharmaceuticals, Inc., a biotechnology company based in San Diego, California committed to developing broad spectrum, antivirals has recently announced that Philippe Gallay of the Scripps Research Institute will be presenting a co-authored abstract ... Read more